低磷饮食对比高磷饮食对慢性肾脏病患者FGF23水平影响的系统评价与荟萃分析
该系统评价与荟萃分析纳入5项随机临床试验共94例血磷正常的3B期CKD患者,比较低磷与高磷饮食对FGF23水平的影响,干预时长1至12周。结果显示低磷饮食有降低FGF23的趋势(SMD -0.74,95%CI -1.54至0.07,P=0.07),且使用完整FGF23检测时降低趋势更明显。
要点
- 低磷饮食对3B期CKD患者FGF23有降低趋势但未达统计学显著。
- 完整FGF23检测法显示更明显的降低趋势,与C端检测法存在交互作用趋势。
- 证据限于短期(1-12周)、小样本血磷正常患者,需谨慎解读。
核心结论
- 短期饮食限磷倾向于降低中度肾功能减退患者的FGF23水平。
- 使用完整FGF23检测时,低磷饮食的降FGF23效应趋势更明显。
研究设计与样本
- 纳入5项随机临床试验,共94例血磷正常的3B期CKD成人患者,研究时长1至12周。
主要发现
- 低磷饮食对比高磷饮食降低FGF23的趋势:SMD -0.74,95%CI -1.54至0.07,P=0.07。
- 完整FGF23检测亚组:SMD -1.14,95%CI -2.24至-0.04。
- C端FGF23检测亚组:SMD -0.05,95%CI -0.67至0.57,亚组间交互P=0.09。
临床怎么用
- 对3B期CKD血磷正常患者,短期低磷饮食可能有助于降低FGF23,但证据尚未确立。
- 临床解读FGF23变化时需注意检测方法(完整FGF23与C端FGF23)的差异。
局限性
- 纳入研究仅5项、样本量小(94例),研究时长较短(1至12周)。
- 研究对象限于血磷正常的3B期CKD患者,结果外推需谨慎。
- 主要结局未达统计学显著性(P=0.07),亚组分析仅为趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated fibroblast growth factor-23 (FGF23) levels increase the risk of cardiovascular diseases in patients with chronic kidney disease (CKD). We aimed to compare the effects of different dietary interventions, lower versus higher phosphate levels, on FGF23 in patients with CKD. METHODS: We conducted electronic literature searches of Medline, PubMed, Embase and the Cochrane Library for publications up to 29 October 2016 for randomized clinical trials that compared lower versus higher phosphate dietary interventions in adults with CKD. The primary outcome was the difference in change-from-baseline FGF23 levels between intervention groups. Considering the difference in measurement units between intact FGF23 and C-terminal FGF23 assays, the treatment effect was analysed as the standardized mean difference (SMD) with the 95% confidence interval (CI). RESULTS: We identified five trials enrolling a total of 94 normophosphataemic patients with Stage 3B CKD. The study duration ranged from 1 to 12 weeks. Compared with higher phosphate diets, lower phosphate diets tended to reduce FGF23 levels (SMD -0.74, 95% CI -1.54 to 0.07, P = 0.07). Subgroup analyses showed a trend (P for interaction = 0.09) towards a better FGF23-lowering effect by lower phosphate diets in studies using the intact FGF23 assay (SMD -1.14, 95% CI -2.24 to -0.04) than those using the C-terminal FGF23 assay (SMD -0.05, 95% CI -0.67 to 0.57). CONCLUSIONS: Short-term dietary phosphate restriction tends to reduce FGF23 levels in patients with moderately decreased kidney function, and the FGF23-lowering effects tend to be more prominent when measured with the intact FGF23 assay.
引用
- Tsai WC, Wu HY, Peng YS, et al. Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018. PMID: 29420827. doi:10.1093/ndt/gfy005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。